Sistem Patent
European Patent (TR Translation)

Anti-B7-H3 Antikorları Ve Antikor İlaç Konjügatları

Invention Abstract

Mevcut buluş, spesifik olarak insan B7-H3'e bağlanan antikor ilaç konjugatlarını (ADC'ler) sağlar. Mevcut buluş, Bcl-xL inhibitörlerini hedef kanser hücrelerine, örneğin B7-H3 eksprese eden hücrelere seçici olarak iletebilen yeni ADC'ler sağlar.       $YUXSD3DWHQWOHULQLQ9HULOPHVLøOHøOJLOL$YUXSD 3DWHQW6|]OHúPHVLQLQ7UNL\H¶GH8\JXODPD ùHNOLQL*|VWHULU<|QHWPHOLN¶LQ XQFXPDGGHVL KNPX\DUÕQFD  İ67(0/(5ø <$<,0/$1$1$9583$ 3$7(17 %$ù9858/$5,  

IPC Classes
C07K 16/28A61K 31/00A61K 39/00
Parties
Inventor
Archana Thakur J. Andrew Souers C. Andrew Phıllıps Lorenzo Benatuıl Kamel Izeradjene Debra Chao Mılan Bruncko S. Andrew Judd
Rights Holder
Abbvıe Inc. North Chıcago, Il 60064 A.B.D.
Attorney
Aylin Şener (Or-Bis Patent Danışmanlık Ticaret Limited Şirketi)

This record is compiled from official TPMK patent bulletins and is provided for information. The abstract text is as published, in Turkish. The current legal status (opposition, assignment, invalidation) requires a full register review. Ask our experts for a comprehensive patent search.